-
CSL Delivers $2.9 Billion Profit, 110 Million Flu Vaccine Doses -
Groundbreaking Asthma Drug Could Revolutionize Treatment
-
Australia Inks Next-Gen mRNA Technology Deal With US
-
Australian University to Collaborate with Moderna for mRNA Vaccine Research
-
Australia Approves First Cell-Based Flu Vaccines For Kids Aged Two and Older
